表紙
市場調査レポート

中国の血圧降下剤市場

Hypertension Drugs Markets in China

発行 Asia Market Information & Development 商品コード 86341
出版日 ページ情報 英文 215 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
中国の血圧降下剤市場 Hypertension Drugs Markets in China
出版日: 2016年05月01日 ページ情報: 英文 215 Pages
概要

当レポートでは、中国の経済動向、血圧降下剤市場の投資環境、産業の発展、需要および供給、産業構造、市場チャネルおよび主要企業などについて詳細に調査し、実績、長期予測を提供しています。

第1章 イントロダクション

  • 本調査書の範囲と方法論
  • エグゼクティブサマリー

第2章 ビジネス環境

  • 経済展望
    • 主な経済指標
    • 工業生産高
    • 人口および労働力
    • 海外からの投資
    • 海外貿易
  • 金融および税金の規制
    • 銀行制度および規制
    • 外国為替
    • 税金、関税および税関

第3章 血圧降下剤産業のアセスメント

  • 産業構造
    • 市場規模
    • 市場成長促進要因
    • 売上高
    • 主要メーカーの設備拠点
    • 主要メーカーの売上高および市場シェア
    • 労働コスト
    • 潜在性のある参入企業
    • 主要流通業者
    • 主な海外からの投資
    • 技術開発

第4章 血圧降下剤の生産および需要

  • 薬剤分類別の市場概要
    • カルシウム拮抗薬
    • アンジオテンシンII受容体拮抗薬
    • アンギオテンシン変換酵素阻害薬
    • その他の血圧降下剤
    • 輸出入
  • メーカー別市場概要
  • 価格動向

第5章 血圧降下剤の市場展望

  • 市場の展望
  • 政府の規制
  • 医療保険産業の概要
  • 消費者支出の動向
  • 人口動向
  • 医療産業の動向
  • 病院および病床
  • 医師および往診

第6章 市場戦略

  • 中国市場参入の概要
    • 流通システム
    • 血圧降下剤の流通チャネル
    • 運輸および輸送インフラ
    • 通信
  • 中国市場への参入
    • 対中国輸出
    • 間接輸出
    • 直接輸出
    • ライセンスおよび提携製造
    • 中国内組み立て
    • 提携製造
    • 貿易許可
    • 投資
    • 資本提携
    • 共同提携
    • 完全外資企業

第7章 血圧降下剤メーカーのディレクトリー

  • メーカーのプロファイルおよび産業における主な消費

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 808

China's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS

  • Hypertension Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Hypertension Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

  • Market Overview by Drugs Classification
  • Calcium Channel Blocker
  • Felodipine
  • Nifedipine
  • Amlodipine
  • Nisoldipine
  • Nimodipine
  • Nitrendipine
  • Angiotensin II Receptor Antagonists Drug
  • Losartan
  • Valsartan
  • Irbesartan
  • Telmisartan
  • Candesartan
  • Angiotensin-Converting Enzyme Inhibitor
  • Benazepril
  • Enalapril
  • Captopril
  • Lisinopril
  • Ramipril
  • Other Hypertension Drugs
  • Import and Export
  • Market Overview by Producers
  • Pricing Trend

V. HYPERTENSION DRUGS MARKET OUTLOOK

  • Hypertension Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. HYPERTENSION DRUGS PRODUCER DIRECTORY

  • Profiles of Hypertension Drugs Producers and Major Consumption in Industry

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS

  • Calcium Channel Blocker Sales Volume and Market Share by Drugs Classification
  • Angiotensin II Receptor Antagonists Drug Sales Volume and Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share by Drugs Classification
  • Other Hypertension Drugs Sales Volume and Market Share by Drugs Classification
  • Hypertension Drugs Sales Volume
  • Major Producer Facility Location
  • Major Hypertension Drugs Producer Sales Volume
  • Major Foreign Investment in China

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

  • Hypertension Drugs Sales Volume by Drugs Classification
  • Calcium Channel Blocker Sales Volume and Market Share by Drugs Classification
  • Angiotensin II Receptor Antagonists Drug Sales Volume and Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share by Drugs Classification
  • Other Hypertension Drugs Sales Volume and Market Share by Drugs Classification
  • Hypertension Drugs Import by Drugs Classification
  • Hypertension Drugs Export by Drugs Classification
  • Hypertension Drugs Major Producer, Sales Volume, and Market Share

V. HYPERTENSION DRUGS MARKET OUTLOOK

  • Consumer Spending Trends
  • The Structure of Per Capita Expenditure in the Northeast of China
  • The Structure of Per Capita Expenditure in the North of China
  • The Structure of Per Capita Expenditure in the Southeast of China
  • The Structure of Per Capita Expenditure in the Central of China
  • The Structure of Per Capita Expenditure in the Southwest of China
  • The Structure of Per Capita Expenditure in the Northwest of China
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

LIST OF CHARTS

I. INTRODUCTION

  • Hypertension Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS

  • Total Hypertension Drugs Sales Volume
  • Hypertension Drugs Sales Volume by Drugs Classification
  • Calcium Channel Blocker Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Market Share by Drugs Classification
  • Angiotensin II Receptor Antagonists Drug Market Share by Drugs Classification
  • Other Hypertension Drugs Market Share by Drugs Classification
  • Hypertension Drugs Sales Volume

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

  • Hypertension Drugs Sales Volume
  • Hypertension Drugs Import
  • Hypertension Drugs Export
  • Hypertension Drugs Sales Volume by Drugs Classification
  • Calcium Channel Blocker Sales Volume and Market Share
  • Calcium Channel Blocker Market Share by Drugs Classification
  • Angiotensin II Receptor Antagonists Drug Sales Volume and Market Share
  • Angiotensin II Receptor Antagonists Drug Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share
  • Angiotensin-Converting Enzyme Inhibitor Market Share by Drugs Classification
  • Other Hypertension Drugs Sales Volume and Market Share
  • Other Hypertension Drugs Market Share by Drugs Classification
  • Hypertension Drugs Import by Drugs Classification
  • Calcium Channel Blocker Import and Market Share
  • Angiotensin II Receptor Antagonists Drug Import and Market Share
  • Angiotensin-Converting Enzyme Inhibitor Import and Market Share
  • Other Hypertension Drugs Import and Market Share
  • Hypertension Drugs Export by Drugs Classification
  • Calcium Channel Blocker Export and Market Share
  • Angiotensin-Converting Enzyme Inhibitor Export and Market Share
  • Angiotensin II Receptor Antagonists Drug Export and Market Share
  • Other Hypertension Drugs Export and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel
Back to Top